Predicting Alzheimer's disease: New project PreTAD launched

The interdisciplinary project PreTAD (Ethical, Clinical, Linguistic and Legal Aspects of the Paradigm Shift towards Predictive Medicine) investigates the individual attitudes and needs of affected persons regarding the prediction of Alzheimer's disease. Furthermore, it examines the effects of the increasing paradigm shift in medicine from the treatment of manifested diseases towards their prediction, from an ethical, linguistic, legal and social perspective.

Along with ceres, the interdisciplinary project team brings together partners from the University of Cologne, the University of Koblenz, the Hôpitaux Universitaire de Genève, and the Fundaciò ACE, Barcelona.

PreTAD is funded by ERA-NET NEURON, which promotes multinational research particularly on neurological diseases, and its national partner institutions. ERA-NET NEURON is one of the European Research Area Networks (ERA-NETs) funded by the European Union as part of the HORIZON 2020 program.
Further information can be found here.